Left Atrial Appendage Exclusion (LAAE) is recommended during heart surgery by The Society of Thoracic Surgeons, American College of Cardiology, and the American Heart Association
When medicine fails, where do you send your Advanced Afib patients? Join us at #ACC24 where our team of experts will be available to discuss Hybrid AF™ Therapy, an effective treatment option for Advanced Afib patients. @American College of Cardiology
#Cardiology
When medicine fails, where do you send your Advanced Afib patients? Join us at #ACC24 where our team of experts will be available to discuss Hybrid AF™ Therapy, an effective treatment option for Advanced Afib patients. @American College of Cardiology
#Cardiology
Elevated CHA2DS2-VASc score, age ≥ 65 years, enlarged left atrium, and NT Pro-BNP increase, but no history of Afib. What do you do?
AtriCure’s LeAAPS™ Trial is investigating LAA exclusion to reduce the risk of stroke in these elevated-risk patients.
Learn more:… https://t.co/4CHCifCIys
Elevated CHA2DS2-VASc score, age ≥ 65 years, enlarged left atrium, and NT Pro-BNP increase, but no history of Afib. What do you do?
AtriCure’s LeAAPS™ Trial is investigating LAA exclusion to reduce the risk of stroke in these elevated-risk patients.
Learn more:… https://t.co/4CHCifCIys
Made with exceptional design and quality, AtriClip® Devices have a polyester fabric cover to promote tissue in-growth, leading to complete encapsulation in 90 days.
Learn more about the most widely implanted LAAM device: https://t.co/JOu2uBydw5#CardioTwitter#Afib#AtriClip
Made with exceptional design and quality, AtriClip® Devices have a polyester fabric cover to promote tissue in-growth, leading to complete encapsulation in 90 days.
Learn more about the most widely implanted LAAM device: https://t.co/JOu2uBydw5#CardioTwitter#Afib#AtriClip
Studies have shown freedom from Afib and a ≥90% reduction in Afib burden when treated with Hybrid AF™ Therapy. Discover how this therapy can improve outcomes for even the most complex arrhythmia patients at #EHRA2024. Learn more: https://t.co/1WZR2bLc2P#HybridAFTherapy
ISI:… https://t.co/j4V5eq8IxK
Studies have shown freedom from Afib and a ≥90% reduction in Afib burden when treated with Hybrid AF™ Therapy. Discover how this therapy can improve outcomes for even the most complex arrhythmia patients at #EHRA2024. Learn more: https://t.co/1WZR2bLc2P#HybridAFTherapy
ISI:… https://t.co/j4V5eq8IxK
AtriCure’s LeAAPS™ Trial is the largest randomized clinical trial in cardiac surgery to date and is investigating LAA exclusion to reduce the risk of stroke in elevated-risk patients with no history of Afib.
To learn more about LeAAPS, visit: https://okt.to/uXEo4W
#ClinicalTrial#Stroke#AtriClip
AtriCure’s LeAAPS™ Trial is the largest randomized clinical trial in cardiac surgery to date and is investigating LAA exclusion to reduce the risk of stroke in elevated-risk patients with no history of Afib.
To learn more about LeAAPS, visit: https://okt.to/uXEo4W
#ClinicalTrial#Stroke#AtriClip
Employees showcased their diverse cultures through cuisine, decorations and attire, embracing our tradition of Journey Around the World. #ThisisAtriCure
Employees showcased their diverse cultures through cuisine, decorations and attire, embracing our tradition of Journey Around the World. #ThisisAtriCure
Congratulations to Melissa Hix, Melissa Haller, Geni Rupley, and Erin Witte on their spotlights in the Cincinnati Business Courier - People on the Move Women’s History Month feature! This recognition highlights the impact they make in business and in their communities. Join us in congratulating them and check out their profiles below:
Melissa Hix: https://okt.to/vc5mIH
Melissa Haller: https://okt.to/A2wKM5
Geni Rupley: https://okt.to/C4DPje
Erin Witte: https://okt.to/c7VvSY
Congratulations to Melissa Hix, Melissa Haller, Geni Rupley, and Erin Witte on their spotlights in the Cincinnati Business Courier - People on the Move Women’s History Month feature! This recognition highlights the impact they make in business and in their communities. Join us in congratulating them and check out their profiles below:
Melissa Hix: https://okt.to/vc5mIH
Melissa Haller: https://okt.to/A2wKM5
Geni Rupley: https://okt.to/C4DPje
Erin Witte: https://okt.to/c7VvSY
AtriCure proudly supports the American Heart Association and their mission to be a relentless force for heathier lives. It was another record year for participation in this year’s Cincinnati Heart Mini! #ThisIsAtriCure
AtriCure proudly supports the American Heart Association and their mission to be a relentless force for heathier lives. It was another record year for participation in this year’s Cincinnati Heart Mini! #ThisIsAtriCure
When medicine fails, where do you send your Advanced Afib patients? Join us at #ACC24 where our team of experts will be available to discuss Hybrid AF™ Therapy, an effective treatment option for Advanced Afib patients. American College of Cardiology
#Cardiology
When medicine fails, where do you send your Advanced Afib patients? Join us at #ACC24 where our team of experts will be available to discuss Hybrid AF™ Therapy, an effective treatment option for Advanced Afib patients. American College of Cardiology
#Cardiology
Elevated CHA2DS2-VASc score, age ≥ 65 years, enlarged left atrium, and NT Pro-BNP increase, but no history of Afib. What do you do?
AtriCure’s LeAAPS™ Trial is the largest randomized clinical trial in cardiac surgery to date and is investigating LAA exclusion to reduce the risk of stroke in these elevated-risk patients.
To learn more about LeAAPS, visit: https://okt.to/9Qk0RJ#ClinicalTrial#Stroke#Strokeprevention#AtriClip
Elevated CHA2DS2-VASc score, age ≥ 65 years, enlarged left atrium, and NT Pro-BNP increase, but no history of Afib. What do you do?
AtriCure’s LeAAPS™ Trial is the largest randomized clinical trial in cardiac surgery to date and is investigating LAA exclusion to reduce the risk of stroke in these elevated-risk patients.
To learn more about LeAAPS, visit: https://okt.to/9Qk0RJ#ClinicalTrial#Stroke#Strokeprevention#AtriClip
Made with exceptional design and quality, AtriClip® Devices have a polyester fabric cover to promote tissue in-growth with complete encapsulation in 90 days.
Learn more about the most widely implanted LAAM device at: https://okt.to/oCDaqh#AtriClip#Afib#CardiacSurgery#LAAE
Made with exceptional design and quality, AtriClip® Devices have a polyester fabric cover to promote tissue in-growth with complete encapsulation in 90 days.
Learn more about the most widely implanted LAAM device at: https://okt.to/oCDaqh#AtriClip#Afib#CardiacSurgery#LAAE
social media channels to keep updated on the latest at AtriCure.